De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
Nuvation Bio Beheer
Beheer criteriumcontroles 2/4
Nuvation Bio's CEO is David Hung, appointed in Apr 2018, has a tenure of 6.5 years. total yearly compensation is $4.32M, comprised of 13.7% salary and 86.3% bonuses, including company stock and options. directly owns 17.71% of the company’s shares, worth $135.75M. The average tenure of the management team and the board of directors is 2.3 years and 1.3 years respectively.
Belangrijke informatie
David Hung
Algemeen directeur
US$4.3m
Totale compensatie
| Percentage CEO-salaris | 13.7% |
| Dienstverband CEO | 6.5yrs |
| Eigendom CEO | 17.7% |
| Management gemiddelde ambtstermijn | 2.3yrs |
| Gemiddelde ambtstermijn bestuur | 1.3yrs |
Recente managementupdates
Recent updates
Nuvation Bio: Continuing To Justify A Buy Thesis With Catalysts In 2024
Aug 08Is Nuvation Bio (NYSE:NUVB) A Risky Investment?
Aug 07
Nuvation Bio: A Potentially Transformative Acquisition
Jun 20Nuvation Bio: Strong Buy Off The Acquisition Of A Late-Stage Lung Cancer Candidate
Mar 31Nuvation: Cash Is King, Science Is An Afterthought
Oct 03We Think Nuvation Bio (NYSE:NUVB) Can Afford To Drive Business Growth
Sep 14Seth Klarman's Baupost adds Herbalife, Altice USA, exits Dropbox, Enhabit
Feb 14We're Hopeful That Nuvation Bio (NYSE:NUVB) Will Use Its Cash Wisely
Feb 10We Think Nuvation Bio (NYSE:NUVB) Can Afford To Drive Business Growth
Nov 09Nuvation Bio GAAP EPS of -$0.12 beats by $0.02
Nov 03Analyse CEO-vergoeding
| Datum | Totale vergoeding | Salaris | Bedrijfswinsten |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | -US$511m |
| Mar 31 2024 | n/a | n/a | -US$69m |
| Dec 31 2023 | US$4m | US$593k | -US$76m |
| Sep 30 2023 | n/a | n/a | -US$83m |
| Jun 30 2023 | n/a | n/a | -US$90m |
| Mar 31 2023 | n/a | n/a | -US$105m |
| Dec 31 2022 | US$8m | US$570k | -US$104m |
| Sep 30 2022 | n/a | n/a | -US$108m |
| Jun 30 2022 | n/a | n/a | -US$103m |
| Mar 31 2022 | n/a | n/a | -US$88m |
| Dec 31 2021 | US$5m | US$550k | -US$87m |
| Sep 30 2021 | n/a | n/a | -US$75m |
| Jun 30 2021 | n/a | n/a | -US$64m |
| Mar 31 2021 | n/a | n/a | -US$53m |
| Dec 31 2020 | US$1m | US$475k | -US$42m |
| Sep 30 2020 | n/a | n/a | -US$38m |
| Jun 30 2020 | n/a | n/a | -US$32m |
| Mar 31 2020 | n/a | n/a | -US$33m |
| Dec 31 2019 | US$364k | US$218k | -US$34m |
Compensatie versus markt: David's total compensation ($USD4.32M) is above average for companies of similar size in the US market ($USD3.23M).
Compensatie versus inkomsten: David's compensation has been consistent with company performance over the past year.
CEO
David Hung (66 yo)
6.5yrs
Tenure
US$4,324,280
Compensatie
Dr. David T. Hung, M.D., serves as Founder, President, Chief Executive Officer and Director at Nuvation Bio Inc since April 2018 and has been it's Chairman of the Board since September 03, 2024. He founded...
Leiderschapsteam
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| Founder | 6.5yrs | US$4.32m | 17.71% $ 135.8m | |
| Chief Scientific Officer | 5.3yrs | US$1.36m | 0% $ 0 | |
| Chief Medical Officer | 2.3yrs | US$1.34m | 0.0027% $ 20.6k | |
| VP of Finance and Principal Accounting & Financial Officer | less than a year | geen gegevens | 0.0032% $ 24.3k | |
| VP of Legal & Secretary | no data | geen gegevens | geen gegevens | |
| Chief People Officer | 5yrs | geen gegevens | 0.0032% $ 24.2k | |
| Chief Technical Operations Officer | 3.3yrs | US$3.31m | 0.0036% $ 27.4k | |
| Chief Regulatory Officer | 2.3yrs | geen gegevens | geen gegevens | |
| Chief Commercial Officer | less than a year | geen gegevens | 0.0075% $ 57.3k | |
| CEO & Co-Founder of AnHeart Therapeutics and Director | less than a year | geen gegevens | 1.68% $ 12.9m |
2.3yrs
Gemiddelde duur
54yo
Gemiddelde leeftijd
Ervaren management: NUVB's management team is considered experienced (2.3 years average tenure).
Bestuursleden
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| Founder | 6.5yrs | US$4.32m | 17.71% $ 135.8m | |
| CEO & Co-Founder of AnHeart Therapeutics and Director | less than a year | geen gegevens | 1.68% $ 12.9m | |
| Independent Director | 4yrs | US$447.77k | 0.075% $ 572.5k | |
| Independent Director | 5.2yrs | US$440.35k | 0.051% $ 394.3k | |
| Member of Scientific Advisory Board | 1.3yrs | geen gegevens | geen gegevens | |
| Independent Director | 5.3yrs | US$448.68k | 0.091% $ 696.4k | |
| Member of Scientific Advisory Board | 1.3yrs | geen gegevens | geen gegevens | |
| Member of Scientific Advisory Board | 1.3yrs | geen gegevens | geen gegevens | |
| Lead Independent Director | 4.3yrs | US$442.60k | geen gegevens | |
| Member of Scientific Advisory Board | 1.3yrs | geen gegevens | geen gegevens | |
| Member of Scientific Advisory Board | 1.3yrs | geen gegevens | geen gegevens | |
| Member of Scientific Advisory Board | 1.3yrs | geen gegevens | geen gegevens |
1.3yrs
Gemiddelde duur
63yo
Gemiddelde leeftijd
Ervaren bestuur: NUVB's board of directors are not considered experienced ( 1.3 years average tenure), which suggests a new board.